Related Experiment Video
Updated: Mar 26, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy
Catherine Morgan1, Geraint Fuller1, Benjamin R Wakerley1,2
1Department of Neurology, Gloucester Royal Hospital, Gloucester, GL1 3NN, UK.
Introduction:
Bifacial weakness with paresthesias is a rare subtype of Guillain-Barré syndrome (GBS), characterized by facial diplegia in the absence of any other cranial neuropathies, limb weakness, or ataxia. Frequently, patients also complain of distal limb paresthesias before or at the time they develop facial weakness.
Methods:
We describe a man who developed post-infective isolated symmetric facial diplegia associated with distal paresthesias. Nerve conduction studies were conducted at 4 time-points over 6 months.
Results:
A monophasic disease course and presence of cerebrospinal fluid albuminocytological dissociation supported a diagnosis of bifacial weakness with paresthesias. Serial nerve conduction studies demonstrated an evolving demyelinating neuropathy with evidence of distal and proximal demyelination without conduction block, which partially resolved over time. Despite complete resolution of facial weakness within weeks, distal paresthesias persisted beyond 6 months.
Conclusions:
This study suggests that neuropathy in patients with bifacial weakness and paresthesias is demyelinating and diffuse.
More Related Videos
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
04:55A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
Published on: May 11, 2022
Related Concept Videos
Diphtheria
Peripheral Artery Disease I: Introduction
Parkinson's Disease: Overview
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation